This article examines how scientists and policymakers are working to ensure that powerful new biotechnology tools are used safely and securely. As genetic engineering and artificial intelligence become more accessible, frameworks are needed to identify potential risks while allowing beneficial research to continue. The authors discuss three emerging areas—microbiome therapies, biohybrid materials, and AI applications—and explain how existing safety frameworks may need updating to address new types of risks beyond traditional biological weapons concerns.